Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,452 Cr
verification pending
Revenue YoY
-1.9%
reported change
EBITDA
Pending
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Colgate-Palmolive India reported Q4 FY25 revenue of INR 1,452 crore, a -1.9% decline YoY, with flat volumes and negative pricing due to elevated trade promotions. Full-year revenue reached INR 5,999 crore, up 6.5% YoY, driven by mid-to-high single-digit volume growth. EBITDA margin for Q4 was 34.3%, supported by cost efficiencies rather than pricing. The company highlighted a softening in urban demand, particularly in the bottom 70% of urban India, while rural remained resilient. Premiumization continues to outperform, with Colgate Total growing at over 4x market growth. Management expects urban demand to recover in the second half of FY26. Key risks include sustained high competitive intensity in trade and potential margin pressure from reinvestments in product quality and brand building.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects the softness in urban demand, particularly in the bottom 70%, to persist in the near term and recover towards the back half of FY26.
- Management reiterated that EBITDA margins will operate in the low 30% range, with potential quarterly fluctuations, supported by cost efficiencies.
- Premium products are expected to continue growing at 4x the rate of the rest of the portfolio, driven by innovation and premium launches.
Risks flagged
- Competitors have increased trade spending, pressuring Colgate's pricing and volumes. Management noted this as an aberration but expects it to persist near-term.
- Softness in urban mass-market demand has led to volume titration by consumers, impacting overall growth. Recovery is uncertain and may take longer than expected.
- Upgrading product formulations and increasing brand investment may pressure margins if cost savings are insufficient to offset these spends.
Key quotes
- We believe that the strategy that we have... is the right strategy. It's working for us, and we will continue to execute against this strategy.
- Our objective would be to drive that top-line both volume and value and what is required to deliver that. I would not give a guidance on any particular level at this point.
- We are not actually seeing down-trading in the market. The reason for the slowing volume growth... is actually consumers titrate the amount of toothpaste that they use.
Research modules